TY - JOUR
T1 - Orally administered mycelial culture of Phellinus linteus exhibits antitumor effects in hepatoma cell-bearing mice
AU - Huang, Hui Yu
AU - Chieh, Shih Yung
AU - Tso, Tim K.
AU - Chien, Ting Yi
AU - Lin, Hsin Tang
AU - Tsai, Ying Chieh
PY - 2011/1/27
Y1 - 2011/1/27
N2 - Aim of the study: The aim of this study was to evaluate the anticancer effect of a mycelial culture from Phellinus linteus PL-7 (MCPL-7) and to elucidate its potential mechanism in vivo. Materials and methods: SCID CB-17 mice received a transplant of Hep3B cells followed by daily MCPL-7 administrations for 8 weeks. Following tumor implantation, groups C-E were subcutaneously administered 50 mg/kg, 100 mg/kg, or 250 mg/kg MCPL-7 powder per day, respectively, for 8 weeks. Groups A and B received saline solution subcutaneously for 8 weeks. Results: MCPL-7 administration induced a significant reduction in tumor size and was associated with a significant increase in T cell numbers; IL-12, IFN-γ and TNF-α secretion; NK cell activity; and phagocytic ability. Therefore, increased numbers of CD4+cells could have been caused by greater numbers of dendritic cells and macrophages in the spleen. Furthermore, the activation of dendritic cells and macrophages resulted in increased IL-12 secretion, which could upregulate NK cell activation. The increased secretion of IL-12, IFN-γ, and TNF-α enhanced the activity and phagocytic ability of NK cells. Thus, MCPL-7 may provide a potential therapeutic approach for both immunomodulatory and antitumor effects.
AB - Aim of the study: The aim of this study was to evaluate the anticancer effect of a mycelial culture from Phellinus linteus PL-7 (MCPL-7) and to elucidate its potential mechanism in vivo. Materials and methods: SCID CB-17 mice received a transplant of Hep3B cells followed by daily MCPL-7 administrations for 8 weeks. Following tumor implantation, groups C-E were subcutaneously administered 50 mg/kg, 100 mg/kg, or 250 mg/kg MCPL-7 powder per day, respectively, for 8 weeks. Groups A and B received saline solution subcutaneously for 8 weeks. Results: MCPL-7 administration induced a significant reduction in tumor size and was associated with a significant increase in T cell numbers; IL-12, IFN-γ and TNF-α secretion; NK cell activity; and phagocytic ability. Therefore, increased numbers of CD4+cells could have been caused by greater numbers of dendritic cells and macrophages in the spleen. Furthermore, the activation of dendritic cells and macrophages resulted in increased IL-12 secretion, which could upregulate NK cell activation. The increased secretion of IL-12, IFN-γ, and TNF-α enhanced the activity and phagocytic ability of NK cells. Thus, MCPL-7 may provide a potential therapeutic approach for both immunomodulatory and antitumor effects.
KW - Antitumor
KW - Immunomodulation
KW - Phellinus linteus
UR - http://www.scopus.com/inward/record.url?scp=78651409986&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78651409986&partnerID=8YFLogxK
U2 - 10.1016/j.jep.2010.10.015
DO - 10.1016/j.jep.2010.10.015
M3 - Article
C2 - 20951789
AN - SCOPUS:78651409986
SN - 0378-8741
VL - 133
SP - 460
EP - 466
JO - Journal of Ethnopharmacology
JF - Journal of Ethnopharmacology
IS - 2
ER -